KRAS and cancer: The lipid kinase PI3Kα was shown to drive initiation of pancreatic cancer downstream of the main driving oncogene of this cancer [5,6,7,8], oncogenic Kras, which is found to be mutated in more than 80% of pancreatic cancer patients.